Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute
Cancer Cytopathology · 2025
DOI: 10.1002/cncy.70057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, 2025. Verfasst von Minhua Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Cytodiagnosis. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Pelvic washing (PW) cytology has been excluded from endometrial cancer staging by the 2009 International Federation of Gynecology and Obstetrics (FIGO) criteria, and its prognostic significance in early stage disease remains controversial. In this study, the authors evaluated the clinicopathologic correlates and prognostic impact of positive PW cytology in a large institutional cohort using a matched case–control design.
Methods
A retrospective case–control cohort was created by reviewing PWs for endometrial cancer from 2013 to 2023 in the authors' pathology database. Cases with positive PW were retrieved from consecutive patients who had FIGO 2009 stage I or II endometrial cancer. The control group was comprised of randomly selected patients with negative PWs who were matched to patients in the positive PW group on patient age, tumor histologic subtype, FIGO grade, and disease stage. Cox proportional hazards models and multivariable logistic regression analyses were used to correlate survival outcomes and to identify predictors of cytologic positivity.
Results
The cohort included 88 patients who had positive PW cytology and 223 matched controls. Positive PW cytology was independently associated with significantly worse disease‐free survival (hazard ratio, 4.33; p < .001) and demonstrated borderline significance for overall survival (hazard ratio, 1.67; p = .05). The presence of free‐floating tumor cells in the fallopian tubes was an independent predictor of positive PW cytology ( p < .001).
Conclusions
The current study demonstrates that positive PW cytology is an independent adverse prognostic factor in patients with stage I/II endometrial cancer and suggests that PW cytology status should be considered for accurate risk stratification of patients who have early stage endometrial cancer although it is not part of the current FIGO staging criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Minhua Wang, Rita Abi-Raad, Adebowale J Adeniran, Guoping Cai, Tong Sun
Zitieren
APA
Wang, M., Abi-Raad, R., Adeniran, A. J., Krishnamurti, U., Buza, N., Hui, P., Cai, G., & Sun, T. (2025). Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute. Cancer Cytopathology. https://doi.org/10.1002/cncy.70057
Vancouver
Wang M, Abi-Raad R, Adeniran AJ, Krishnamurti U, Buza N, Hui P, et al. Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute. Cancer Cytopathology. 2025. doi:10.1002/cncy.70057
BibTeX
@article{Wang2025,
author = {Wang, Minhua and Abi-Raad, Rita and Adeniran, Adebowale J and Krishnamurti, Uma and Buza, Natalia and Hui, Pei and Cai, Guoping and Sun, Tong},
title = {Prognostic significance of pelvic washing cytology in early stage endometrial cancer: A 10‐year matched cohort analysis from a large single institute},
journal = {Cancer Cytopathology},
year = {2025},
doi = {10.1002/cncy.70057}
}
EUVIMED